Literature DB >> 17039375

Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential.

Margaret Buckingham1, Lola Bajard, Philippe Daubas, Milan Esner, Mounia Lagha, Frédéric Relaix, Didier Rocancourt.   

Abstract

The transcription factors Pax3 and Pax7 are important regulators of myogenic cell fate, as demonstrated by genetic manipulations in the mouse embryo. Pax3 lies genetically upstream of MyoD and has also been shown recently to directly control Myf5 transcription in derivatives of the hypaxial somite, where it also plays an important role in ensuring cell survival. Both Pax3 and Pax7 are expressed in myogenic progenitor cells derived from the central dermomyotome that make a major contribution to skeletal muscle growth. In Pax3/Pax7 double mutants, the myogenic determination genes, Myf5 and MyoD, are not activated in these cells which become incorporated into other tissues or die. This again demonstrates the dual function of Pax factors in regulating the entry of progenitor cells into the myogenic programme and in ensuring their survival. Pax3 expression marks cells in the dermomyotome that either become myogenic or downregulate Pax3 and assume another cell fate. The latter include the smooth muscle cells of the dorsal aorta that share a common clonal origin with the skeletal muscle of the myotome, thus illustrating the initial multipotency of Pax3 expressing cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17039375     DOI: 10.1007/s00429-006-0122-0

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  25 in total

1.  Essential role for Dicer during skeletal muscle development.

Authors:  Jason R O'Rourke; Sara A Georges; Howard R Seay; Stephen J Tapscott; Michael T McManus; David J Goldhamer; Maurice S Swanson; Brian D Harfe
Journal:  Dev Biol       Date:  2007-08-25       Impact factor: 3.582

Review 2.  Defining the transcriptional signature of skeletal muscle stem cells.

Authors:  Z Yablonka-Reuveni; K Day; A Vine; G Shefer
Journal:  J Anim Sci       Date:  2007-09-18       Impact factor: 3.159

3.  Lineage-specific responses to reduced embryonic Pax3 expression levels.

Authors:  Hong-Ming Zhou; Jian Wang; Rhonda Rogers; Simon J Conway
Journal:  Dev Biol       Date:  2007-12-27       Impact factor: 3.582

4.  miR-26a is required for skeletal muscle differentiation and regeneration in mice.

Authors:  Bijan K Dey; Jeffrey Gagan; Zhen Yan; Anindya Dutta
Journal:  Genes Dev       Date:  2012-10-01       Impact factor: 11.361

Review 5.  Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways.

Authors:  Nadège Zanou; Philippe Gailly
Journal:  Cell Mol Life Sci       Date:  2013-04-04       Impact factor: 9.261

6.  Taf1 regulates Pax3 protein by monoubiquitination in skeletal muscle progenitors.

Authors:  Stéphane C Boutet; Stefano Biressi; Kevin Iori; Vanita Natu; Thomas A Rando
Journal:  Mol Cell       Date:  2010-12-10       Impact factor: 17.970

7.  Maternal obesity downregulates myogenesis and beta-catenin signaling in fetal skeletal muscle.

Authors:  Jun F Tong; Xu Yan; Mei J Zhu; Stephen P Ford; Peter W Nathanielsz; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-27       Impact factor: 4.310

8.  Assessment of disease activity in muscular dystrophies by noninvasive imaging.

Authors:  Katie K Maguire; Leland Lim; Sedona Speedy; Thomas A Rando
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

Review 9.  In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease.

Authors:  Alastair Khodabukus; Neel Prabhu; Jason Wang; Nenad Bursac
Journal:  Adv Healthc Mater       Date:  2018-04-25       Impact factor: 9.933

Review 10.  Nitric oxide in myogenesis and therapeutic muscle repair.

Authors:  Clara De Palma; Emilio Clementi
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.